XFOR - Financial Reports List - X4 Pharmaceuticals, Inc. - IntrinsicAlpha

X4 Pharmaceuticals, Inc. XFOR

Healthcare - Biotechnology - NASDAQ - US

$ 2.71

2.21 %

$ 15.7 M

Market Cap

1.31

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	100.54%	74.68%
Quarterly Report	Q4	8-K	2024-12-31	-53.14%	-108.16%	-41.73%
Annual Report	FY	10-K	2024-12-31	0.00%	62.98%	66.15%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-1492.02%	-26.77%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	263.04%	375.54%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	7.08%	-44.50%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	20.36%	-10.01%
Annual Report	FY	10-K	2023-12-31	0.00%	-7.78%	-22.79%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	92.08%	-6.40%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-162.64%	-25.45%

1